Key Takeaways
- Clinical Bottom Line
- Ending Senseless Pathology Billing
Clinical Bottom Line
| Polyp Presentation | Optical Architecture (NBI) | 2026 Pathological Protocol |
|---|---|---|
| Tiny (<5mm) Left-Sided Polyp | Pale, visually lacks brown capillary networks (NICE Type 1). | Clinically diagnosed as Hyperplastic. Resect and physically discard into the suction trap. Zero pathology bill. |
| Tiny (<5mm) Right-Sided Polyp | Pale, covered in mucus. | Must assume it is a Sessile Serrated Lesion (SSL). Mandatory extraction and formal pathological review. |
Ending Senseless Pathology Billing
Historically, the fear of missing a tiny cancer drove a highly defensive dogma: every single fragment of tissue removed from the colon must be sent to an expensive third-party pathological laboratory in a formalin jar. This practice resulted in millions of healthcare dollars wasted annually confirming that tiny 3mm bumps in the rectum were entirely benign, un-mutated hyperplastic polyps with zero malignant potential.
Relying on Optical Competence
The ASGE rigidly endorsed the “Resect and Discard” paradigm explicitly for diminutive (≤5mm) polyps found exclusively in the rectosigmoid. By heavily utilizing NBI (Narrow Band Imaging) optical enhancements, an expert endoscopist can confidently visually confirm the complete lack of chaotic brown vascularity that defines an adenoma. The physician simply cold-snares the tiny bump, allows it to wash away into the suction machine, and digitally stamps the procedure report declaring an “Optical diagnosis of hyperplastic polyp,” drastically reducing the patient’s out-of-pocket facility bill while maintaining exceptional safety.
Clinical guidelines summarized by the Gastroscholar Research Team. Last updated: 2026. This article is intended for physicians.
